Overview

Evaluation of the Efficacy and Safety of Diclofenac HPBCD 25, 50 mg/ml in the Treatment of Post-surgical Pain Following Dental Surgery

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

The present study is proposed to evaluate the efficacy and safety of single doses of Diclofenac HPBCD subcutaneous (s.c.) (25 mg/1 ml and 50 mg/1 ml) in the treatment of acute moderate-to-severe pain after dental impaction surgery.

Phase:

Phase 3

Details

Lead Sponsor:

IBSA Institut Biochimique SA

Treatments:

Diclofenac